Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

KBI Biopharma

Request full access

KBI Biopharma | World Class CMO/CDMO Biologics Services

Durham, United StatesFounded 1996Biotech & Life Sciences

About KBI Biopharma

KBI Biopharma is a Contract Development and Manufacturing Organization (CDMO) that specializes in accelerating the development of innovative biological products. The company serves a diverse range of clients, including early-stage biotech firms, global pharmaceutical companies, and academic non-profit organizations. KBI Biopharma operates in the biopharmaceutical market, focusing on transforming scientific discoveries into life-changing medicines. The business model is centered around providing rapid cell line generation services using established mammalian and microbial recombinant protein expression systems, such as CHO K1, CHO S, CHO DG44, HEK293, and DXB11 E. coli. These services are designed to meet the timeline and budgetary objectives of preclinical programs. KBI Biopharma generates revenue through its comprehensive suite of development and manufacturing services, which include both standalone cell line development and fully integrated process development programs. The company aims to reduce risk and build value for its clients while expanding global access to essential medicines.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1,694
Open positions
54
Dealroom signal
39.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Drug Development, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2C
Investment activity
8 companies, latest Jan 2020
Capital deployed
$48M
Preferred round
SERIES A

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Oct 2025 $100M $399M Jsr ↗
FundingOther financing Dec 2016 $0 — Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

KBI Biopharma website traffic

Latest recorded traffic for KBI Biopharma is 100K monthly website visits, up 29.9% over the last three months. KBI Biopharma's team grew 2.2% over the past year.

Latest monthly visits100K 3-month web change+29.9% 1-year team growth+2.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

KBI Biopharma in the Durham ecosystem

Live from Dealroom

The KBI Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Jsr
Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
16 countries with
team presence
🇺🇸 United States92.2%
🇨🇭 Switzerland4.7%
🇫🇷 France1.7%
🇮🇹 Italy0.1%
🇯🇵 Japan0.1%
Top 5 of 16 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about KBI Biopharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See KBI Biopharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.